SH3PXD2A
Summary:
| Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
|---|---|---|---|---|---|
| SH3 and PX domains 2A | Ensembl:ENSG00000107957 | HGNC:HGNC:23664 | PA134956816 | 10q24.33 |
GO terms in SH3PXD2A
| Term Type | Evidence Type | GO Term ID | GO Des. |
|---|---|---|---|
| CC | IDA | GO:0002102 | podosome |
| CC | TAS | GO:0005829 | cytosol |
| CC | IEA | GO:0030054 | cell junction |
| CC | IEA | GO:0042995 | cell projection |
| BP | IBA | GO:0006801 | superoxide metabolic process |
| BP | IDA | GO:0006801 | superoxide metabolic process |
| BP | IMP | GO:0006801 | superoxide metabolic process |
| BP | TAS | GO:0030198 | extracellular matrix organization |
| BP | IEA | GO:0043085 | positive regulation of catalytic activity |
| BP | IMP | GO:0072675 | osteoclast fusion |
| MF | IEA | GO:0002020 | protease binding |
| MF | IPI | GO:0005515 | protein binding |
| MF | IEA | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding |
| MF | IEA | GO:0010314 | phosphatidylinositol-5-phosphate binding |
| MF | IBA | GO:0016176 | superoxide-generating NADPH oxidase activator activity |
| MF | IEA | GO:0032266 | phosphatidylinositol-3-phosphate binding |
| MF | IBA | GO:0035091 | phosphatidylinositol binding |
| MF | IEA | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding |
| MF | IEA | GO:0070273 | phosphatidylinositol-4-phosphate binding |
Gene expression in normal tissue: SH3PXD2A
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in SH3PXD2A
| Database | Pathway ID | Pathway Des. |
|---|---|---|
| reactome | R-HSA-1474244 | Extracellular matrix organization |
| reactome | R-HSA-8941237 | Invadopodia formation |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in SH3PXD2A
CLASSFICATION
Copyright © 2018 Modellab | All Rights Reserved
Disclaimer: iGMDR is intended for research purposes only. Its information cannot be used for emergencies or medical or professional advice.